Log in

NASDAQ:MTBCMTBC Stock Price, Forecast & News

$7.29
-0.11 (-1.49 %)
(As of 06/4/2020 04:00 PM ET)
Add
Compare
Today's Range
$7.08
Now: $7.29
$7.43
50-Day Range
$5.92
MA: $6.48
$7.40
52-Week Range
$3.25
Now: $7.29
$7.75
Volume144,300 shs
Average Volume164,542 shs
Market Capitalization$90.40 million
P/E RatioN/A
Dividend YieldN/A
Beta1.11
MTBC, Inc., a healthcare information technology (IT) company, provides an integrated suite of Web-based solutions and related business services to healthcare providers primarily in the United States. The company operates through two segments, Healthcare IT and Practice Management. It primarily offers PracticePro, a software-as-a-service platform, which includes practice management software and related tools that facilitate the day-to-day business operation and workflows; electronic health record (EHR), which enables customers to reduce paperwork; revenue cycle management services, such as end-to-end medical billing, analytics, and related services; and mobile health solutions, including smartphone applications that assist patients and healthcare providers in the provision of healthcare services. The company also provides a web-based EHR solution; healthcare claims clearinghouse services; transcription, coding, indexing, and other ancillary services; electronic data interchange services; talkEHR, a voice enabled EHR solution; business intelligence, customized applications, interfaces, and various other technology solutions; comprehensive practice management services; telemedicine services; and patient experience management solutions. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinical staff that render bills for their services. The company was formerly known as Medical Transcription Billing, Corp. and changed its name to MTBC, Inc. in February 2019. MTBC, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.
Read More
MTBC logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.33 out of 5 stars


Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MTBC
CUSIPN/A
Phone732-873-5133

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$64.44 million
Cash Flow$0.33 per share
Book Value$3.51 per share

Profitability

Net Income$-870,000.00

Miscellaneous

Employees2,700
Market Cap$90.40 million
Next Earnings Date8/5/2020 (Estimated)
OptionableNot Optionable

Receive MTBC News and Ratings via Email

Sign-up to receive the latest news and ratings for MTBC and its competitors with MarketBeat's FREE daily newsletter.

MTBC (NASDAQ:MTBC) Frequently Asked Questions

How has MTBC's stock been impacted by COVID-19 (Coronavirus)?

MTBC's stock was trading at $5.31 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MTBC stock has increased by 37.3% and is now trading at $7.29. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of MTBC?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MTBC in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for MTBC.

When is MTBC's next earnings date?

MTBC is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for MTBC.

How were MTBC's earnings last quarter?

MTBC, Inc (NASDAQ:MTBC) posted its earnings results on Thursday, May, 14th. The technology company reported ($0.42) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.64) by $0.22. The technology company had revenue of $21.87 million for the quarter, compared to the consensus estimate of $21.37 million. MTBC had a negative net margin of 6.41% and a negative return on equity of 10.63%. View MTBC's earnings history.

What guidance has MTBC issued on next quarter's earnings?

MTBC updated its FY 2020 Pre-Market earnings guidance on Thursday, May, 14th. The company provided EPS guidance of for the period. The company issued revenue guidance of $100-102 million, compared to the consensus revenue estimate of $98.1 million.

What price target have analysts set for MTBC?

5 analysts have issued 12-month price objectives for MTBC's stock. Their forecasts range from $6.40 to $8.50. On average, they anticipate MTBC's share price to reach $7.60 in the next twelve months. This suggests a possible upside of 4.3% from the stock's current price. View analysts' price targets for MTBC.

What are Wall Street analysts saying about MTBC stock?

Here are some recent quotes from research analysts about MTBC stock:
  • 1. March quarter report yesterday validates CareCloud integrationabove and beyond our expectations, but.... MTBC reported 1Q20sales of $21.9M, up 45% from 1Q19's $15.1M on an apples-to-orangesbasis in light of the January 8 closing of CareCloud and the expectedincremental $30-31M in additive sales contribution this year. Further andinterestingly, MTBC has launched its formal "MTBC Force" initiative, amercenary approach to providing services to companies that have greatcustomer interface, but are perhaps weaker on the cost efficiency sideof service and support infrastructure. With three such deals under theirbelt, MTBC management appeared calm, cool, and not exceedinglyambitious in again delivering its $100-102M in sales guidance for 2020yesterday" (5/15/2020)
  • 2. We reiterate our Buy rating on MTBC following Q1 results that beat expectations acrossrevenue, EBITDA and EPS. Q1 was the first quarter in which the CareCloud acquisitioncontributed, and registered a small top-line beat relative to our expectations. Owingto COVID and the precipitous decline in physician visits entering Q2, MTBC expectsQ2 to be down sequentially, with negative EBITDA and EPS. This is not a surprise asfully 60% of MTBC revenue is dependent on physician volumes and charges. Still, MTBCreiterated its full-year view of $100M to $102M in revenue and $12-$13M EBITDA asit has multiple paths to get there, namely its growing Force partner program, and verylikely an acquisition of a tuck-in nature. Depending on the size of the deal, we thinkMTBC could exceed guidance, but for now we have not built any acquired growth in ourmodel and remain slightly below management’s outlook." (5/15/2020)

Has MTBC been receiving favorable news coverage?

Media headlines about MTBC stock have trended very negative this week, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. MTBC earned a news sentiment score of -3.2 on InfoTrie's scale. They also assigned headlines about the technology company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the immediate future. View the latest news aboutMTBC.

Are investors shorting MTBC?

MTBC saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 162,700 shares, an increase of 26.7% from the April 30th total of 128,400 shares. Based on an average trading volume of 202,500 shares, the days-to-cover ratio is presently 0.8 days. Approximately 2.5% of the company's shares are sold short. View MTBC's Current Options Chain.

Who are some of MTBC's key competitors?

What other stocks do shareholders of MTBC own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MTBC investors own include Inseego (INSG), NVIDIA (NVDA), Square (SQ), Marvell Technology Group (MRVL), iCAD (ICAD), InVitae (NVTA), Alibaba Group (BABA), Crispr Therapeutics (CRSP), EXACT Sciences (EXAS) and Aptiv (APTV).

What is MTBC's stock symbol?

MTBC trades on the NASDAQ under the ticker symbol "MTBC."

Who are MTBC's major shareholders?

MTBC's stock is owned by a number of institutional and retail investors. Top institutional investors include EAM Investors LLC (1.19%), Acadian Asset Management LLC (0.78%), Globeflex Capital L P (0.73%), Hancock Whitney Corp (0.24%) and Franklin Resources Inc. (0.12%). Company insiders that own MTBC stock include A Hadi Chaudhry, Bill Korn, Cameron Munter, John N Daly, Kimberly J Grant, Mahmud Ul Haq, Shruti H Patel and Stephen Andrew Snyder. View institutional ownership trends for MTBC.

Which major investors are selling MTBC stock?

MTBC stock was sold by a variety of institutional investors in the last quarter, including Hancock Whitney Corp. Company insiders that have sold MTBC company stock in the last year include A Hadi Chaudhry, Bill Korn, Cameron Munter, John N Daly, Kimberly J Grant, Mahmud Ul Haq, and Shruti H Patel. View insider buying and selling activity for MTBC.

Which major investors are buying MTBC stock?

MTBC stock was bought by a variety of institutional investors in the last quarter, including EAM Investors LLC, Globeflex Capital L P, Acadian Asset Management LLC, and Franklin Resources Inc.. View insider buying and selling activity for MTBC.

How do I buy shares of MTBC?

Shares of MTBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MTBC's stock price today?

One share of MTBC stock can currently be purchased for approximately $7.29.

How big of a company is MTBC?

MTBC has a market capitalization of $90.40 million and generates $64.44 million in revenue each year. The technology company earns $-870,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis. MTBC employs 2,700 workers across the globe.

What is MTBC's official website?

The official website for MTBC is www.mtbc.com.

How can I contact MTBC?

MTBC's mailing address is 7 CLYDE ROAD, SOMERSET NJ, 08873. The technology company can be reached via phone at 732-873-5133.

This page was last updated on 6/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.